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Abstract
The influenza virus uses the hemagglutinin (HA) and neuraminidase (NA) glycoproteins to interact with and infect host cells.
While biochemical and microscopic methods allow examination of the early steps in flu infection, the genesis of progeny
virions has been more difficult to follow, mainly because of difficulties inherent in fluorescent labeling of flu proteins in a
manner compatible with live cell imaging. We here apply sortagging as a chemoenzymatic approach to label genetically
modified but infectious flu and track the flu glycoproteins during the course of infection. This method cleanly distinguishes
influenza glycoproteins from host glycoproteins and so can be used to assess the behavior of HA or NA biochemically and
to observe the flu glycoproteins directly by live cell imaging.
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Introduction
Enveloped viruses are composed of elements produced by and
recruited from the infected cell. The formation of new virus particles
occurs either on intracellular membranes or at the plasma
membrane. The assembly of a nascent virion requires the coalescence
of the envelope (glyco)proteins embedded in a proper lipid
environment, and the recruitment of matrix and nucleocapsid
proteins together with the viral genome [1–3]. How apposition of
envelope components and viral genomes are controlled as a means of
ensuring production of infectious progeny is not well understood.
The influenza virus particle contains a segmented, negative
stranded RNA genome encoding 11 proteins, two of which the virus
uses to interact with the host cell membrane [4]. Hemagglutinin
(HA), a type I transmembrane protein, binds to sialoglycoconjugates
on the surface of the host cell and mediates entry of the viral particle
[5,6]. HA also mediates fusion of the viral and host cell membranes
to effectuate genome delivery to the cell to be infected [7].
Neuraminidase (NA), a type II membrane protein, is a sialidase that
assists in release of virions from the infected cell [8].
The inability to label either flu HA or NA in a manner that
allows continuous monitoring of surface disposition, surface
distribution, and release has hampered the study of flu particle
biogenesis. The use of antibodies, while feasible in principle,
requires their introduction as fluorophore-conjugates that would
crosslink viral proteins unless used as monovalent F(ab) fragments.
Moreover, this labeling method is indirect. Studies that address
particle biogenesis have also mostly used fixed cells and by design
have not addressed virus release in real time. Visualization of the
influenza glycoproteins in living cells demands a method for site-
specifically modifying HA and NA, at the exclusion of all host
proteins inserted into the very same membrane. We know of no
successful attempts to achieve this by genetically tagging the flu
glycoproteins with fluorescent proteins or with other methods that
yield visible HA or NA by covalent modification in the context of
an infectious virus.
We and others have developed a site-specific labeling method
that exploits sortase transpeptidases found in gram positive
bacteria [9,10]. These enzymes cleave the five amino acid
LPXTG recognition sequence between the threonine and glycine
residues, forming an acyl-enzyme intermediate that is resolved by
nucleophilic attack by the N-terminus of an oligoglycine peptide,
forming a new amide bond. This reaction is portable: upon
incubation with recombinant sortase A, proteins that carry an
LPXTG motif are readily labeled with oligoglycine-based probes
bearing a broad range of functionalities [11,12]. The incoming
nucleophile may carry any desired substituent for attachment,
including fluorophores, biotin, lipids, or may even consist of other
polypeptides- see [13], for review.
Here we report the creation of two influenza A/WSN/33
strains bearing the sortase cleavage site in the HA and NA proteins
respectively. Infection of host cells with such strains allows site-
specific labeling of HA or NA and allows us to observe the
products of influenza infection in real time. We can thus visualize
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and examine biochemically the events that immediately precede
viral release from the host cell surface, as well as the release of
newly formed virus particles. The ability to execute sequential
labeling reactions employing distinct tags allowed us to observe
preferred sites from which virus particles are released.
Results
Generation of recombinant A/WSN/33 influenza viruses
for sortase labeling
While purified virus particles can be labeled with lipophilic dyes,
the dequenching of which reports on fusion of the incoming viral
envelope with target endosomal membranes [14,15], the produc-
tion of new virions is more difficult to visualize. Neither flu
neuraminidase nor hemagglutinin tolerate fusion to fluorescent
proteins or other modules that allow site-specific covalent
attachment of fluorophores—attempts to do so are incompatible
with virus production and assembly. For N-terminal fusions to NA,
this is likely the result of failure to insert into the ER during its
biosynthesis. The bulky GFP moiety, when fused to the C-
terminus of NA, likely compromises its functional activity and
oligomerization. For HA, the only viable option would be to place
GFP at the C-terminus, but fusions as small as a (His)6 epitope
already impair virus assembly and fusogenic activity of HA [16].
Fusions to the N-terminus of mature HA have been reported [17],
but with the caveat that such fusions undergo significant
proteolysis and yield substantial amounts of wild-type HA protein.
The inability to specifically label the flu glycoproteins for
biochemical and visual observation has hampered an analysis of
the virus budding process.
We devised a sortase-based labeling method to overcome at
least some of these limitations, and our findings are likely to be
more generally applicable to other viruses with problematic
labeling characteristics when relying on fusion with fluorescent
proteins. The sortase labeling (sortagging) method is particularly
well-suited for labeling of type II membrane proteins, as has been
done for CD40L [11], CD74 and Dectin-1 [18] at the
extracellularly exposed C-terminus. We installed an LPETG motif
at the C-terminus of the A/WSN/33 NA protein, followed by an
HA epitope tag (this epitope is absent from the A/WSN/33
hemagglutinin) (Figure 1A). Because the portion distal to the
cleavage site is lost upon sortagging, the presence of the epitope tag
allows monitoring of material not accessible to the enzyme in
intact cells. We used the 12 plasmid reverse genetics system to
generate recombinant A/WSN/33 flu particles bearing this
sortaggable NA construct [19], and found that the resulting virus
was infectious and indistinguishable from wild type virus in its
ability to replicate in vitro (Figure 1B). We refer to this strain as
NA-Srt.
HA is a type I membrane protein, synthesized as an HA0
precursor, which requires proteolytic cleavage by a trypsin-like
activity to generate the disulfide-bonded HA1 and HA2 subunits.
This cleavage exposes a key glycine residue at the N-terminus of
HA2 that is essential for HA2 to retain its fusogenic activity [5].
We created a version of HA that allows trypsin cleavage in the
loop that connects HA1 and HA2, with concomitant exposure of
the sortase recognition sequence (placed immediately upstream of
the trypsin cleavage site). Cleavage is likely to improve accessibility
of the LPXTG motif, a requirement for efficient labeling [11,20].
We therefore generated a recombinant A/WSN/33 flu strain
bearing this sortaggable HA, and found that this strain, too, was
not attenuated in vitro (Figure 1C). We refer to this strain as HA-
Srt. The behavior of the NA-Srt virus was indistinguishable from
that of the WSN parental strain when assessing virulence by
monitoring weight loss in mice. Mice infected with sublethal doses
of the HA-Srt virus also showed weight loss, albeit somewhat
reduced compared to mice infected with wild-type virus.
(Figure 1D). We conclude that the installation of a sortase tag
on either NA or on HA does not seriously impair virus assembly,
virus release and infectivity in vitro and in vivo.
Sortase-mediated labeling of NA-Srt and HA-Srt virions
and infected cell surfaces
We obtained NA-Srt virions by sedimentation from the
supernatants of infected MDCK cells, and subjected this material
to sortagging with a biotinylated probe, followed by detection of
biotinylated material by immunoblotting. Only in the presence of
sortase and probe did we detect specific labeling, accompanied by
the loss of the HA epitope tag, as expected. Based on the intensity
of the HA-positive materials recovered, we estimate that the
labeling efficiency of HA in the sedimented virus is approximately
70–80% for the conditions used (Figure 2A). This value is not
atypical for sortase-mediated labeling reactions, which usually
proceed to near-completion [11,21]. Using sortase we similarly
installed TAMRA or Alexa647 dyes on intact virions pelleted from
tissue culture supernatant or further purified through a sucrose
gradient (Figure 2A and Figure 2B). Dimerization of the NA-
Srt protein incorporated into gradient-purified virions is unaffect-
ed by the LPETG tag (Figure 2C)
We infected MDCK cells with the NA-Srt virus and at different
times post infection, we subjected cells to sortagging with a
biotinylated triglycine-based probe (Figure 2D). We detected
biotinylated, surface accessible NA by immunoblotting using
streptavidin-HRP. We assayed for the unlabeled and cell-internal
pools of NA by reactivity with an anti-HA epitope antibody. NA
was first detectable at ,1 hr post-infection and its levels peaked at
,4 hrs, after which we observed no further increase. Sortase-
mediated surface biotinylation of NA was detectable at 4 hrs post-
infection and steadily increased over the duration of the
experiment (7 hrs). Specificity of labeling is excellent: we observed
no host cell proteins modified with the biotinylated probe.
Cells infected with the HA-Srt virus can be similarly labeled.
Glycosidase digestions confirm that sortase labels only the cell
surface pool of flu glycoproteins (Figure 2E), as follows. We
Author Summary
Enveloped viruses such as the influenza virus cause
significant disease in humans. In order to cause a
productive infection, the virus particle must interact with
the host cell using the viral proteins encoded within its
genome. For many such viruses, it is possible to directly
observe the early steps in infection, yet for technical
reasons it has been extremely difficult to study the genesis
of daughter virions as they bud off of infected host cells.
Here we devised a chemoenzymatic labeling strategy to
site-specifically append probes to the influenza hemag-
glutinin (HA) and neuraminidase (NA) proteins using the
bacterial sortase A enzyme. Because labeling is confined to
surface exposed HA and NA in the context of live, infected
cells, it is possible to study budding biochemically and
microscopically in real-time. Using this system, we can
observe budding of flu virions from discrete sites at the
cell surface. Our work will enable detailed investigation
into the birth of viruses from infected host cells and can
likely be applied to viruses other than influenza that have
been similarly resistant to real-time microscopic observa-
tion during budding.
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labeled intact cells infected with either the HA-Srt or NA-Srt
viruses with sortase using a biotinylated probe, followed by lysis
and digestion with either Endoglycosidase H or PNGaseF.
Immunoblotting showed that all of the biotinylated HA-Srt
protein is partially EndoH-resistant, indicating successful traversal
of the secretory pathway. Because mature NA and HA carry both
complex-type and high mannose-type oligosaccharides [22,23],
resistance to digestion with EndoH is always partial, as seen by
comparison with the PNGaseF digestion product. The entire
unlabeled, anti-HA reactive pool of NA-Srt protein was fully
EndoH-sensitive, however, as evident from a comparison with the
PNGaseF digestion products. The fraction of NA-Srt inaccessible
to sortagging is thus indeed composed of cell-internal NA-Srt
protein. We conclude that only the cell surface pool of influenza
glycoproteins, poised for incorporation into nascent virions, is
labeled upon incubation of infected cells with sortase and a
suitable probe.
Biochemical study of flu release from infected cells
Having established the specificity of labeling of the sortagging
method, we examined the biogenesis of flu virions and their release
from infected cells through biochemical analysis and by live cell
imaging. We labeled flu HA-Srt protein on the surface of infected
and metabolically labeled cells by exposure to trypsin, followed by
sortase-mediated installation of a single biotin at the C-terminus of
HA1. We performed a pulse-chase experiment to examine the
kinetics of arrival of HA-Srt protein at the cell surface, and its
subsequent release from the infected cell as assembled virions. We
did not ascertain the presence of all subgenomic RNA fragments
in the material released from the infected cell, as we have no
means of testing whether individual particles carry a full
complement of subgenomic RNAs, or whether the released
materials contain substantial amounts of defective particles with
incomplete sets of RNAs. However, our data are consistent with
the release of HA-Srt into the medium corresponding to assembly
and release of progeny virions (see below).
We initiated metabolic labeling with 35S labeled Cysteine/
Methionine at ,5 hours post-infection, a time when robust viral
protein synthesis is ongoing. For some experiments, we infected
cells at a low multiplicity of infection (MOI) (Figure 3A), and
started metabolic labeling at 14 hrs post-infection, when most of
the cells are infected by progeny HA-Srt virus produced by the
cells infected initially. In this setting, we observe a similar if not
greater amount of labeling than for cells infected at a high MOI
(Figure 3D), indicating that the LPETG-tag is neither lost nor
interferes with virus replication (compare Figure 3B and
Figure 3E). During the chase, we performed sortase labeling for
30 minutes at the indicated time points. We lysed the 35S-labeled
sortagged cells and subjected them to affinity purification on a
neutravidin-agarose matrix to recover the biotin-modified HA1
and associated proteins (Figure 3B). At the 0 min time point of
this experiment (it includes a 30 minute incubation with sortase,
during which intracellular transport of glycoproteins continues), no
labeled HA1 is recovered, indicating that the newly synthesized
pool of HA requires at least 30 minutes to reach the cell surface.
We observe a steady increase in surface exposed (sortase
accessible) HA-Srt protein as well as a minor fraction of associated,
uncleaved HA0. We attribute the presence of this HA0 to
incomplete cleavage of the HA trimer by trypsin added to the
medium. In this manner we recover -as part of a trimer- some
HA0 devoid of biotin, along with the sortase modified, biotinylated
HA. As expected, we do not observe biotinylated HA0 by
streptavidin blot (data not shown). We do observe a small amount
of HA0 at the cell surface at the 0 min timepoint. This we attribute
to a minor portion of labeled HA1 not detectable via
autoradiography. The HA0 recovered at early time points is
composed of both the mature HA0 and the high mannose
intermediate (Figure 3C). As expected, HA1 and HA2 are
recovered together because of their covalent association, which
persists after cleavage of HA0. We examined the behavior of HA-
Srt protein at later chase times (Figure 3E and Figure 3F) and
again observed an increase in labeling, after which the amount of
labeled HA-Srt protein decreases. By 10 hours of chase, less than
20% of the material that successfully reached the cell surface and is
labeled by sortase is retrieved from the cells, indicating that most,
but not all HA labeled in the course of the pulse is released from
the cell, presumably as intact virions. As infected cells show clear
signs of cytopathic effects at late time points post-infection, cellular
functions required for virion assembly are likely to be compro-
mised, thus preventing complete release of all viral products, a
situation that likely applies in vivo as well.
To determine the fate of surface-labeled HA-Srt, we subjected
infected cells to metabolic 35S –Met/Cys pulse labeling, followed
by a chase period of 2 hours to allow radioactive HA-Srt protein
to accumulate on the cell surface (Figure 4A). We labeled intact
infected cells with sortase A and a biotinylated probe and
recovered biotinylated HA-Srt protein from cell lysates as well as
from the media (Figure 4B and Figure 4C). We observe a
gradual increase in HA-Srt released into the media over time,
corresponding to the rate of loss of biotinylated HA-Srt from the
cell surface (Figure 4D bottom panel). However, we detect
more released HA-Srt protein than is accounted for by the loss
from the cell surface (Figure 4D, top panel). We attribute this
difference to the fact that biotinylated HA-Srt is tightly associated
with non-biotinylated HA-Srt in intact virus particles, which are
retrieved by the neutravidin-agarose matrix along with the
sortagged fraction. Metabolically labeled HA-Srt does not bind
non-specifically to this matrix, as virus-infected cells exposed to the
biotinylated probe in the absence of added sortase do not show
any signal.
Does the decrease in cell-associated, biotinylated HA1,
accounted for by the appearance of biotinylated HA-Srt protein
in the supernatant, correspond to the release of virus particles? To
demonstrate this, we recovered from tissue culture supernatants
radiolabeled viral proteins not modified by sortase through
adsorption of released virions onto chicken erythrocytes
(Figure 4E), and visualized the adsorbed materials by SDS-
PAGE and autoradiography. Because binding of the virions to
Figure 1. Generation of sortase compatible influenza viruses. (A) Structural representation of sortase cleavage site mutations in
hemagglutinin and neuraminidase. Sortase cleavage sites including residues that remain with the labeled species (green) and those lost after
sortase-medaited transpeptidation (red) were engineered into the indicated positions in hemagglutinin (left) and neuraminidase (right). Cartoons of
crystal structures are depicted on top (PDB ID for HA: 1HA0, NA: 2HTY). (B) NA-Srt multistep replication assay. NA-Srt virus and wild-type WSN
virus (n = 3) were used to infect MDBK monolayers at an MOI = 0.001 and viral supernatant was plaqued on MDCK cells at the indicated times. (C) HA-
Srt multistep replication assay HA-Srt and wild-type WSN virus (n = 3) were used to infected MDCK monolayers at an MOI = 0.001 and viral
supernatant was analyzed via standard hemaggutination assays. Shown are the last dilution factors at which hemagglutination of red blood cells still
occurs. (D) Infectivity of engineered viruses. Mice (n = 4 in each group) were inoculated with 40000 pfu of the indicated virus and body weight
was monitored at the indicated intervals. Shown is the mean and SEM.
doi:10.1371/journal.ppat.1002604.g001
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erythrocytes occurs via HA, any other protein recovered by low
speed sedimentation of erythrocytes must be part of an adsorbed
virus particle. Indeed, we detect the other viral proteins upon
suitable exposure of the autoradiograms. These include polypep-
tides with the assigned molecular masses of the RNA polymerase
subunits, as well as NP and M1, all of them in quantities
proportional to their methionine/cysteine content and to the
reported copy numbers in intact virions [24]. We next compared
the kinetics of HA accumulation in the media for the fractions
recovered via Neutravidin-agarose or on chicken erythrocytes.
Levels of total HA at the 1 hr time point were quantified and all
other time points were normalized to these values (Figure 4F).
We observe indistinguishable kinetics for HA-Srt accumulation in
the media, underscoring our conclusion that biotinylation does not
affect budding of HA-Srt.
Visualization of influenza glycoproteins in living, infected
cells
Having established the specificity of the labeling reaction and
the ability of the labeled flu glycoproteins to be incorporated into
virions and released into the culture supernatant, we next
visualized virus budding and release by labeling biotinylated,
surface exposed HA-Srt protein with streptavidin-modified
quantum dots. To examine the behavior of surface disposed
HA-Srt and its release from infected cells using a similarly
modifiable control protein as a reference, we generated an MDCK
cell line stably transduced with CD154/CD40L, equipped with a
sortase tag [11]. Like the NA-Srt and HA-Srt proteins, this
molecule is readily labeled with biotin using sortase, yet should not
be actively incorporated into nascent virions and so allows for a
direct comparison with flu HA-Srt.
Incubation of MDCK cells that display biotinylated HA-Srt or
CD154 were readily labeled with quantum dots. We examined the
fluorescence intensity as a function of time after labeling by
cytofluorimetry of infected, labeled cells (Figure 5A). Whereas the
levels of fluorescence recorded for labeled CD154/CD40L were
constant, those for labeled HA-Srt decreased exponentially over
the first few hours of incubation. When we infected labeled
CD154/CD40L-expressing cells with wild type WSN virus, we
also observed constant staining intensity but at a lower level,
presumably because host protein synthesis was much reduced in
the virus-infected cells. Labeled CD154/CD40L is obviously not
incorporated into budding virions.
We labeled HA-Srt infected MDCK cells grown on glass
coverslips with sortase A and biotinylated oligoglycine probe,
followed by staining with streptavidin-functionalized quantum
dots. Cells prepared in this manner were directly imaged by
spinning disc confocal microscopy to observe the behavior of the
HA-Srt protein during the course of virus production and release.
The influenza glycoproteins are known to be inserted into host cell
membrane regions referred to as lipid rafts, operationally defined
as insoluble in non-ionic detergents. One key component of lipid
rafts is the ganglioside, GM1, the levels of which oscillate with cell
cycle status [25]. We co-stained HA-Srt labeled cells with
fluorescently labeled cholera toxin (CTx), a marker for GM1,
and observed variable CTx staining between MDCK cells,
presumably because of asynchronous growth and rapid internal-
ization of CTx [20]. Uninfected MDCK cells show similar
heterogeneous CTx staining, indicating that virus infection is not
the cause of this variability (data not shown). We observe co-
localization of CTx with patches of quantum dot staining in HA-
Srt infected cells (Figure 5B), but in CD40L/CD154 labeled cells,
quantum dot staining shows only partial overlap with CTx
staining, reflecting broad distribution of labeled CD154 in the cell
membrane (Figure 5B). Where there are patches of quantum dot-
stained HA-Srt, we see evidence of CTx colocalization, while for
quantum dot labeled CD154, this is not always the case. Of note,
cells that do not stain with CTx nonetheless label perfectly well
with streptavidin-modified Qdots (and hence correspond to flu-
infected cells) in a pattern that is indistinguishable from that seen
in the adjacent, CTx positive cells. Although GM1 is a raft
component, the organization of the plasma membrane apparently
does not require its presence in a CTx-reactive form for the
organization of HA-Srt.
We conducted a pulse labeling experiment using sortase to
determine the fate of HA-Srt protein labeled with biotin and
streptavidin modified Qdots, followed by a second round of site-
specific labeling with an oligoglycine based Alexa fluor 488 probe
[18] to distinguish this second pool of labeled material from the
first round of labeled HA-Srt, at a later stage of maturation and
virus budding. Infected cells were first labeled with sortase and a
biotinylated probe, followed by staining with streptavidin quantum
dots (HA-Qdot). After 30 minutes, this first pulse was followed by
a second round of labeling using sortase A and an oligoglycine-
Alexa 488 probe (HA-488) at 4uC to inhibit endocytosis of free dye
(Figure 6A, Figure S1). When labeling with the Alexa488 probe
is initiated directly after quantum dot staining, we observe clear
colocalization of the Qdot signal with the Alexa488 signal for most
of the patches, and this is reflected as an increase in the overlap
coefficient of the Qdot signal with the Alexa488 signal over time
(Figure 6A and Figure 6B, Supporting Figure S1). Given the
near quantitative labeling we observe for HA at the cell surface,
the Alexa488-labeled pool of HA must therefore correspond to
HA molecules inserted at sites where HA, labeled with Qdots in
the first round of sortagging, has coalesced. These insertion sites
appear as discrete dots. When Alexa 488 staining is initiated at
Figure 2. Engineered viruses are sortase substrates. (A) NA-Srt virus is a sortase substrate. NA-Srt virus bearing a sortase cleavage site
appeneded to the C-terminus of neuramindase, followed by an HA epitope, was pelleted from tissue culture supernatant and incubated with 150 mM
sortase A and 5 mM of the indicated probe at 37uC for 1 hour, with agitation. Streptavidin-HRP immunoblot (top panel) shows incorporation of a
G3K(Biotin) probe with concomitant loss of the HA epitope (middle blot). A glycine based tetramethylrhodamine probe can also be incorporated
(bottom panel, fluorescence gel). (B) Highly purified NA-Srt virus is labeled with a glycine based AlexaFluor 647 probe. NA-Srt virions
were purified through a 20% sucrose cushion and further banded on a continuous 15–60% sucrose gradient before labeling with sortase (200 mM)
and an AlexaFluor 647 probe (500 mM) for 2 hours at 37uC. The labeling reaction was fractionated by 12.5% SDS-PAGE and scanned by a Typhoon
Imager. (C) NA-Srt protein incorporated into virions is quantitatively forms disulfide bonded dimers. NA-Srt virus was purified over a
sucrose gradient and loaded on a 12.5% SDS-PAGE gel in the presence or absence of reducing agent (2-mercaptoethanol). Anti-HA epitope
immunoblot displays the presence of the NA-Srt protein. (D) Neuraminidase on infected MDCK cell surfaces is selectively labeled by
sortase A. MDCK cells were infected at MOI = 0.5 and at the indicated times post infection, were incubated for 30 min with 200 mM SrtA and 500 mM
biotinylated nucleophile. Cells were collected, subjected to 12.5% SDS-PAGE, and immunoblots with streptavidin-HRP (top), anti-HA (middle), and
anti-p97 (bottom, loading control) were performed. (E) Glycosidase digestions of cell surface labeled HA-Srt protein. MDCK cells were
infected at an MOI of 0.4 overnight and labeled for 1 hour at 37uC with 100 mM sortase and 500 mM biotin probe. Cells were then lysed in
glycoprotein denaturing buffer and digested with either PNGase F or EndoH, resolved by 12.5% SDS-PAGE, transferred to nitrocellulose, and used for
immunoblotting with the indicated antibodies.
doi:10.1371/journal.ppat.1002604.g002
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Figure 3. Surface distribution of HA-Srt measured via pulse-chase analysis. (A) Experimental setup. Confluent layers of MDCK cells were
infected at an MOI of 0.05 for 13 hrs, starved for 60 minutes and labeled with [S35]Cysteine/Methionine for 20 minutes. Cell surface accessible HA-Srt
was labeled for 30 minutes with 100 mM sortase and 250 mM biotin probe at the indicated timepoints. (B) Pulse-chase analysis of virus budding
Sortagging Influenza Proteins to Study Biogenesis
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later time points, HA-488 is located not only in previously
established HA-Qdot patches, but we observe the presence of an
increasing number of new Alexa488 spots of HA-Srt outside of the
Qdot patches. This results in a decrease in the overlap coefficient
of the HA-488 signal with the Qdot signal over time (Figure 6B).
The majority of HA-Qdot remains co-localized with HA-488 over
the course of the experiment (Figure 6B), suggesting that new HA-
Srt is continuously being exported to the same membrane patches
during budding. However, while colocalization with HA488 persists,
both the number of HA-Qdot patches as well as their intensity
decreases over time when compared to HA-488 (Figure 6A,
Figure S1). Although it is a formal possibility that budding may not
have been completed during the 2–3 hour interval, these observa-
tions may also suggest that patches of HA-Srt on the cell surface
serve as sites of multiple budding events. At the 3 hr timepoint, little
of the initial HA-Qdot signal remains, paralleling exactly the
decrease observed by flow cytometry (Figure 5A). A substantial HA-
Qdot signal remains and is found inside cells instead of at the cell
surface at later timepoints (Figure 6C). The release of HA-Qdot
tagged virus in the confined environment of this tissue culture
experiment unavoidably leads to adsorption and internalization of
labeled virus by adjacent, uninfected as well as onto already infected
cells. Labeling with Alexa-488 probe increases at every time point,
consistent with continued output of HA-Srt.
We next studied the behavior of HA-Srt at the cell surface in real
time by timelapse imaging (Figure 7A). We labeled HA-Srt with
biotin probe and streptavidin-Qdots at 4 hours post infection and
acquired images over the following 60 minutes. We see a clear
disappearance of HA-Qdot from the infected cells over this time
course (Figure 7A). We do not see this loss of Qdot signal in
CD154/CD40L-expressing cells labeled in the same fashion
(Figure 7B). This loss of Qdot signal is apparent when the total
sum of pixel intensities is plotted (Figure 7C). The initial increase
seen in CD154/CD40L control cells is likely due to a slight
movement of the cells which cannot be restricted in our system and
indicates that the decrease in HA-Qdot signal seen must be a
minimum estimate of HA-Qdot release. We also observe an
increase in clustering of the Qdot patches over time in the CD154/
CD40L control cells. This may also account for the increase in
signal intensity, as clustering of quantum dots is known to increase
the on-time of blinking Qdots [26] Timelapse movies show a similar
decrease in Qdot signal for the infected cells relative to the CD154/
CD40L-expressing control cells (data not shown).We detect both an
apparent decrease in the total number of patches as well as a
decrease in the intensity. This is in agreement with the observations
made by flow cytometry (Figure 5A) and the timecourse of pulse
labeling with sortase (Figure 6A, Figure S1).
Discussion
For viruses such as vaccinia virus, which tolerates GFP
extensions in many of the proteins it encodes, direct visualization
of viral replication has provided major insights into the
interactions between host cell and pathogen [27]. For viruses
such as flu that are refractory to labeling with fluorescent proteins,
other methods are urgently needed. We here devised a system to
observe the behavior of influenza glycoproteins in cells infected
with a fully functional virus. Our approach leverages the sortase
labeling technique through the generation of influenza viruses that
carry the short sortase recognition sequences in their glycopro-
teins, resulting in minimally modified viral gene products in the
context of an infectious particle. Upon infection of tissue culture
cells, the engineered viruses show behavior identical to the
parental strain in terms of infectivity, replication kinetics, and viral
protein synthesis. Observation of the sortase-labeled glycoproteins
thus reflects very well the behavior of their wild-type counterparts.
By combining this labeling approach with live-cell imaging, we can
monitor the behavior of the influenza glycoproteins in real time.
We observe extensive colocalization of surface-disposed flu
glycoproteins with lipid rafts, as inferred from staining with
CTx. In MDCK cells, flu HA and NA are enriched in lipid rafts
based on their transient insolubility in cold TX100 and on
colocalization with CTx [28].
Several aspects deserve emphasis. First, the specificity of the
reaction and its reliance on an active enzyme limit all labeling to
proteins that bear the sortase recognition sequence. We have not
detected spurious incorporation of label into proteins not
specifically designed to serve as sortase substrates. This applies
not only to our earlier results with CD154/CD40L [11], dectin-1
and CD74 [18], but is extended here to flu NA and HA. The
requirement for proteolytic conversion of HA0 into HA1 and HA2
suggested the possibility of installing a sortase motif upstream of
the trypsin cleavage site without affecting the folding or fusogenic
activity of the HA1-HA2 heterodimer, and our results validate this
approach. Second, the glycosidase digestions performed on HA
and NA unequivocally demonstrate the selectivity of the sortase
reaction for fully mature surface-disposed proteins. In this regard,
the method compares favorably in terms of ease and specificity
with other chemical (iodination, biotinylation) or enzymatic
(lactoperoxidase-catalyzed iodination) surface labeling methods,
whose products require additional purification steps to enable
analysis of the protein(s) of interest. Third, the size of the
substituents introduced is minimal compared to that of a
fluorescent protein such as eGFP or other enzymatically active
modules used for site-specific covalent modification [29]. Given
the failure to construct infectious flu when incorporating GFP into
any of its structural proteins including NA and HA, the small size
of our probes and the choices of label available have enabled, for
the first time, the visualization of flu release from the surface of
infected cells in real time. Fourth, it is possible to perform
sequential labeling experiments and install labels that distinguish
between each pool of labeled protein, and so independently
monitor each pool of labeled product. This allowed us to generate
a starting population of HA-positive cells labeled with quantum
shortly after labeling. Cells were lysed in 0.5% NP-40 lysis buffer and biotin labeled HA-Srt was recovered via immunoprecipitation on streptavidin-
agarose for 3 hrs. A 5% aliquot of the total cell lysate was removed prior to the immunoprecipitation (left panel). Bound complexes were eluted from
beads with 26SDS sample buffer, resolved by 12.5% SDS-PAGE and visualized via autoradiography (right panel). (C) Glycosidase treatment of the
cell lysate. A fraction of the total cell lysate at the 90 minute timepoint was denatured in glycoprotein denaturing buffer and digested with either
PNGase F or EndoH. Proteins were resolved by 12.5% SDS-PAGE and visualized via autoradiography. (D) Experimental setup. Confluent layers of
MDCK cells were infected with an MOI = 0.5 for 4.5 hrs, starved for 60 minutes and labeled with [S35] Cysteine/Methionine for 20 minutes. Cell surface
accessible HA-Srt was labeled for 30 minutes with 100 mM sortase and 250 mM biotin probe at the indicated timepoints. (E) Surface behavior of
HA-Srt analyzed via pulse chase analysis. MDCK cells were lysed at the indicated timepoints and analyzed as in 3B. Cells infected with HA-Srt for
3 h but not treated with sortase and uninfected cells were similarly analyzed (right two lanes). Densitometric quantification of radioactivity was
performed to calculate the ratio of HA0 over HA1 and HA2. (F) Quantification of surface HA-Srt Densitometric quantification of radioactivity was
performed to quantify the total levels of HA-Srt at the cell surface. The amount at t = 4 hrs was set at 100% to and other levels compared in…
doi:10.1371/journal.ppat.1002604.g003
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dots, from which we generated, at set intervals, a second population
of cells with a distinct label installed on HA. Using this approach we
demonstrate that HA-Srt, labeled in a first round of sortagging,
identifies patches into which HA, tagged in a subsequent round of
labeling, is inserted. Although it is possible that budding may not
have been completed within this time interval (2–3 hours), an
alternative interpretation is the existence of specialized sites that
serve as a platform for coalescence of viral glycoproteins (a typical
flu virion requires some 400 HA and 30 NA molecules). Whether
the identity of such patches corresponds to lipid rafts or
specializations of lipid rafts is not clear, but the ability to visualize
such sites opens the possibility of identifying host factors that control
the construction of these sites as launching pads for new virions. We
anticipate that this system will yield a robust method to visualize the
kinetics of particle formation and, in combination with perturba-
tions of host cells, will reveal host proteins that contribute to the
process of influenza virion biogenesis.
Materials and Methods
Ethics statement
All animal protocols were conducted in accordance with the
Guide for the Care and Use of Laboratory Animals of the National
Institutes of Health. All animals were maintained according to the
guidelines of the MIT Committee on Animal Care (CAC). These
studies were approved by the MIT CAC (protocol#1011-123-14).
All infections were performed under avertin anesthesia, and all
efforts were made to minimize suffering.
Protein production and peptide probe synthesis
Sortase was produced as described (Popp et al., 2007). Peptide
probes were produced as described [18].
Generation of recombinant viruses
Mutant viruses were generated by reverse genetics using
plasmids as described [19]. The hemagglutinin and neuraminidase
plasmids were modified by standard molecular biology techniques
to carry the sortase cleavage site. All viruses, including the wild-
type WSN virus used were rescued as described [19]. Nucleotide
and protein sequences for modified portions of flu glycoproteins
are below.
Protein and nucleotide sequence of HA WT (WSN)
Protein Sequence (Trypsin cleavage site is in bold)
…CPKYVRSTKLRMVTGLRNIPSIQYRGLFGAIAGFIEG-
GWTGMIDGWYGYHHQNEQGSGYAA…




Protein and nucleotide sequence of HA-Srt
Protein Sequence (Sortase recognition site is in italics, trypsin
cleavage site is in bold)
…CPKYVRSTKLRMVTGLRNIPSIQYLPETGGRGLFGAI-
AGFIEGGWTGMIDGWYGYHHQNEQGSGYAA…
Nucleotide Sequence (Sortase recognition site is in italics,











Protein and nucleotide sequence of NA-Srt
Protein Sequence (Sortase recognition site is in italics, HA
epitope is in bold)
…SGSIISFCGVNGDTVDWSWPDGAELPFTIDKGGGGS-
LPETGGYPYDVPDYA-
Nucleotide Sequence (Sortase recognition site is in italics, HA




Stable transduction of MDCK cells
CD154/CD40L bearing an LPETG tag [11] was cloned into
pLHCX and used to make retrovirus as described [30]. Retrovirus
was used to infect MDCK cells as described [30] and cells were
selected in 250 mg/ml Hygromycin B.
Figure 4. Site-specifically labeled HA-Srt protein is incorporated into virions. (A) Experimental setup. Confluent monolayers of MDCK
cells were infected with an MOI = 0.5 during 4.5 hours after which cells were starved and pulse-labeled with [S35]Cysteine/Methionine for 20 minutes.
After a 2 hour chase, a second pulse-labeling was performed using 100 mM sortase and 250 mM biotin probe to label surface accessible HA-Srt. At
indicated timepoints, both cell supernatant as well as cell lysate was analyzed for presence of viral proteins. (B) Surface behavior HA on infected
MDCK cells analyzed via affinity adsorption to neutravidin-agarose. At indicated timepoint, cells were lysed in 0.5% NP40 buffer and biotin
labeled HA-Srt remaining at the cell surface recovered via affinity adsorption on neutravidin-agarose. Proteins were eluted with 26 SDS sample
buffer, resolved by 12.5% SDS-PAGE and visualized via autoradiography. (C) Accumulation of HA-biotin in supernatant analyzed by affinity
adsorption to neutravidin-agarose. Accumulation of biotin-HA-Srt in the supernatant of the cells analyzed in 4B was measured via
immunoprecipitation on neutravidin-agarose. Supernatant was lysed via addition of NP40 buffer prior to biding to beads. Proteins were eluted with
26 SDS sample buffer, resolved by 12.5% SDS-PAGE and visualized via autoradiography. (D) Quantification of HA loss from the cell surface.
Densitometric quantification of radioactivity was performed on autoradiographs from figure 4B and 4C. Total levels of HA-Srt were quantified relative
to the levels at the cell surface at t = 0 hrs (top graph). To quantify the kinetics of budding, loss of HA-Srt from the cell surface was quantified as
percent reduction relative to the t = 0 timepoint at the cell surface. The rate of accumulation in the cell supernatant was quantified relative to the
maximal amount recovered at the t = 10 hrs timepoint. (E) Accumulation of whole virus particles analyzed by affinity adsorption to
chicken erythrocytes. Accumulation of complete virus particles in the cell supernatant was measured via affinity adsorption on chicken
erythrocytes. Supernatant from cells analyzed in 4B was removed at indicated timepoints and mixed with chicken erythrocytes for 30 minutes at 4uC.
Cells and bound viral particles were lysed in 26 SDS sample buffer, proteins resolved on 12.5% SDS-PAGE and visualized via autoradiography. (F)
Kinetcs of virus accumulation as analyzed by adsorption to neutravidin-agarose versus erythrocytes. Densitometric quantification of
radioactivity was performed to compare the rate of HA-Srt accumulation in the supernatant compared to whole viral particles (4C versus 4E).
Numbers were normalized at t = 1 hrs at which both methods were used.
doi:10.1371/journal.ppat.1002604.g004
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Viral assays
Viral titer was assessed by plaque assay on MDCK cells as
described [28]. For multi-step replication assays, MDBK cells were
infected at an MOI of 0.001 and incubated for the indicated times
in viral growth medium (VGM, DME with 0.3% BSA)
supplemented with 0.5 mg/ml TPCK-treated trypsin (NA-Srt) or
1 mg/ml TPCK treated trypsin (HA-Srt). For NA-Srt multi-step
replication, 100 ml of media was plaqued at the indicated time
points on MDCK cells grown with 0.5 mg/ml TPCK-trypsin. For
HA-Srt, HA-Srt and wild-type WSN virus (n = 3) were used to
infected MDCK monolayers at an MOI= 0.001 and viral
supernatant was analyzed via standard hemagglutination assays.
Viral particle purification
Viral particles from tissue culture supernatant were concentrated
by pelleting through a 20% sucrose cushion (Sigma) at 25000 rpm
in an SW-28 rotor for 120 minutes. Where indicated, virus was
further purified through a continuous 15%–60% sucrose gradient,
centrifuged at 30,200 rpm in an SW-40.1 rotor for 3 hours.
Sortase labeling of virions
For biotin and TAMRA labeling, virions were pelleted from
tissue culture supernatant without a sucrose cushion. The pellet
was resuspended in 16 sortase buffer and labeled with 150 mM
sortase A/5 mM probe for 1 hour at 37uC. For Alexa647 probe
labeling, sucrose gradient purified virions were mixed with
200 mM sortase A and 500 mM probe at 37uC for 2 hours.
Sortase labeling of live cell surfaces for immunoblot
MDCK cells were plated in a 24 well dish at 70% confluency
the night before the experiment. Cells were infected at an MOI of
1 and 0,1,2,3,4,5,6 or 7 hours post infection, cells were incubated
with 100 mM sortase A and 100 mM G5K-biotin probe [11] in
VGM for 30 minutes at 37uC. Cells were washed extensively in
PBS, collected, and lysed in 1% SDS with protease inhibitor
cocktail (Roche). A BCA assay was performed (Pierce) and 20 mg
of lysate was loaded for western blotting.
Mouse infections
Mice (n = 4 in each group) were inoculated intranasally with
40000 pfu of the indicated virus and body weight was monitored
at the indicated intervals. Balb/C mice and B6129SF2/J mice
were purchased from the Jackson Laboratory (stock# 000651 and
101045 resp). Mice were anesthetized with Avertin and infected
intranasally with 40.000 PFU WT, HA-Srt or NA-Srt virus.
Infection was followed by daily monitoring of weight loss and
animals were euthanized with C02 when weight loss exceeded
20% of initial body weight.
Cell surface labeling and glycosidase digestion
MDCK cells were infected at an MOI of 0.4 overnight and
labeled for 1 hour at 37uC with 100 mM sortase and 500 mM
biotin probe. Cells were then lysed in glycoprotein denaturing
buffer (New England Biolabs) and total protein in lysates were
quantiatated by BCA assay (Pierce). Five micrograms of cell lysate
was digested with either PNGase F or EndoH according to
manufacturer’s directions (New England Biolabs), resolved by
12.5% SDS-PAGE, transferred to nitrocellulose, and used for
western blotting with the indicated antibodies.
Pulse chase experiments
MDCK cells were grown in 6-well tissue culture dishes and
infected with HA-Srt at either an MOI 0.05 for 14 hrs or MOI 0.5
for 4.5 hrs as indicated in figure legends. Cells were starved with
methionine- and cysteine-free DMEM for 45 minutes at 37uC
followed by a 20 minute pulse labeling with [S35]Cysteine/
Methionine (perkin elmer) at 0.77 mCi/ml in methionine- and
cysteine-free DMEM. Chase was initiated by addition of VGM
supplemented with 1 mM methionine, 0.2 mM cysteine and
1 mg/ml TPCK treated trypsin. At indicated timepoints during
chase, cell surface HA molecules were labeled with 0.25 mM
G3K-Biotin and 0.1 mM SrtAureus for 30 minutes at 37u.
Analysis of cell lysate. Cells were washed 3 times in PBS
and lysed in NP40 lysis buffer (0.5%NP40, 150 mM NaCl, 5 mM
MgCl2, 25 mM Tris pH 7.4). Immunoadsportions were
performed with 35 ml Neutravidin (Thermo Scientific) agarose
for 2 hrs at 4uC after an inital preclear of 4–10 hrs using 120 ml
Immobilized protein A beads (Repligen). Immune complexes were
eluted by boiling in reducing sample buffer, subjected to 10%
SDS-PAGE and visualized by autoradiography.
Analysis of cell supernatant. For analysis of virus proteins
in supernatant, cells were infected and pulse labeled as described
above and subsequently incubated with 1 ml VGM supplemented
with 1 mg/ml trypsin-TPCK at 37uC. At indicated timepoints,
supernatant was collected and residual cells removed by short
centrifugation. For immunoadsorption, virus was lysed by addition
of NP40 lysis buffer to a final concentration of 0.5% NP40. Biotin
labeled HA molecules were recovered via immunoadsorption on
35 ml neutravidin after a 4 hr preclear with 40 ml immobilized
protein A beads. Immunecomplexes were eluted by boiling in
reducing sample buffer, subjected to 10% SDS-PAGE and
visualized by autoradiography.
For analysis of total levels of radiolabeled virus, cell supernatant
was incubated for 1 hr with 8E6 chicken red blood cells at 4uC
under gentile agitation. Erythrocytes and bound virus were
collected via centrifugation, lysis in NP40 lysis buffer containing
DNAse and further lysed by bioling and scraping in reducing
sample buffer. Viral proteins were visualized by autoradiography
after 10% SDS-PAGE.
Densitometric quantification of radioactivity was performed on
a PhosphorImager (Fujifilm BAS-2500) using Image Reader BAS-
2500 V1.8 software (Fujifilm) and Multi Gauge V2.2 (Fujifilm)
software for analysis.
Analysis of Qdot labeled virus via flow cytometry
MDCK cells or CD154 control cells were cultured o/n in 24-
well tissueculture dishes. Cells were infected with HA-Srt or WT
Figure 5. Visualization of HA-Srt protein by site-specific sortase labeling followed by streptavidin-Qdot staining. (A) Budding of
Qdot labeled virus analyzed via flow cytometry. Confluent MDCK cells or CD154/CD40L expressing MDCK cells were infected with HA-Srt or
Wild-type virus at an MOI = 1 for 4 hrs. Cell surface accessible HA-Srt or CD154 was labeled for 30 minutes with biotin using 100 mM sortase and
250 mM biotin probe. Biotin labeled surface molecules were further labeled via a 5 minute incubation with 20 nM Qdot655 or 10 nM Qdot655 in the
case of uninfected CD154/CD40L expressing MDCK cells. Total fluorescent intensity of the cells was measure via flow cytometry at the indicated
timepoints. (B) HA-Srt colocalizes with lipid rafts at the cell surface. Confluent layers of MDCK cells were infected at an MOI of 0.35–0.5 for
4.5 hours. Cell surface molecules of infected MDCK cells or CD154/CD40L expressing MDCK cells were labeled with 100 mM sortase and 250 mM biotin
probe for 30 minutes. Biotin labeled HA-Srt of CD154 were further labeled with 20 nm and 10 nm Qdot655 respectively and lipid rafts were stained
with 20 mg/ml CT-B conjugated to Alexa fluor 594. Images were acquired immediately after staining. Scale bars = 5 mm.
doi:10.1371/journal.ppat.1002604.g005
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virus at an MOI of 1. At 4 hrs post-infection, cell surface
molecules were labeled by addition of 0.1 mM Srtaureus and
0.25 mM G3K-Biotin for 30 minutes at 37uC. Cells were washed
in PBS and incubated for 5 minutes with either 20 nM qdot655
(MDCK cells and CD154 cells infected with WT-WSN) or 10 nM
qdot655 (CD154 cells). Cells were incubated at 37uC and at
Figure 6. Visualization of HA-Srt behavior by site-specific pulse labeling using sortase A. (A) Time course of surface appearance of
HA-Srt protein. Experimental setup is depicted on top. MDCK cells were infected with HA-Srt and labeled with 250 mM biotin probe using 100 mM
sortase followed by labeling with Qdot655. At indicated timepoints after the initial labeling, a second round of labeling was performed using sortase
and Alexafluor 488 probe for 60 minutes at 4uC. Images were acquired immediately after labeling. Scale bars = 5 mm. (B) Overlap coefficients. The
overlap coefficients for Qdot655 signal with the AF488 signal and the AF488 signal with the Qdot655 signal are displayed for the images shown in
figure 6A as well as the images from Supporting Fig. S1 (n = 10). (C) Intracellular appearance of Qdot655 conjugated HA-Srt. Spinning disc
confocal microscopy images were taken of the samples from figure 6A (stained with AF488 and Qdot655) at a focal plane midway through the cells in
order to visualize both plasma-membrane as well as the intracellular space, where Qdots accumulate at later timepoints (t = 3 h). Scale bars = 5 mm.
doi:10.1371/journal.ppat.1002604.g006
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indicated timepoints collected via addition of trypsin and kept on
ice. Cells were analyzed immediately on a FACSCalibur flow
cytometer (BD Biosciences) and FlowJo software.
Confocal microscopy
MDCK cells or CD154/CD40L expressing MDCK cells were
cultured in 35 mm glass bottom dishes (MatTek Corporation) and
infected with HA-Srt or WT virus at an MOI of 0.35–0.5 for
4 hours. Cell surface molecules bearing the LPETG motif were
labeled by incubation with 0.1 mM SrtAaureus and 0.25 mM G3K-
biotin for 30 minutes at 37uC. Cells were washed and incubated
with 20 nM (MDCK) or 10 nM (CD154) qdot655 (Invitrogen) for
5 minutes. After extensive washing, cells were incubated with VGM
containing 1 mg/ml trypsin-TPCK. For surface labeling with
(G)3K-Alexafluor 488 probe, cells were incubated with 0.1 mM
SrtAaureus and 20 nM probe for 1 hr at 4uC to inhibit non specific
endocytosis of free dye. For staining of lipid rafts, cells were stained
with 20 mg/ml Alexa fluor 594 conjugated choleratoxinB dye
(invitrogen) for 5 minutes at room temperature immediately
following Qdot labeling and imaging performed directly after.
Images were acquired using an Andor Revolution spinning disk
system with Yokogawa CSU-X1 spinning disk head, Andor iXon+
EM-CCD camera, 488 nm diode laser for excitation, emission
discrimination with an emission filterwheel, Piezo Z100 z-stage on a
Nikon Ti-E motorized microscope stand with a 10061.49NA Plan
Apochromatic objective all controlled with the Andor iQ2 software
(version 2.0). Temperature, CO2 and humidity was controlled with
a LiveCell stage-top incubation system (Pathology Devices).
Analysis was performed using Imaris, Volocity and ImageJ
software. For colocalization analysis, background correction was
applied using ImageJ background correction with a rolling ball
radius of 20 pixels. Images were further analyzed with Volocity
colocalization analysis software. Background threshold was
manually set using a background ROI to correct side effects of
possibly remaining background pixels.
Imaris software was used for analysis of timecourse Z-stack
series. Brightness of images was adjusted using the linear stretch
algorithm with the maximum set to 55. Background was corrected
for using a 17 mm filter width. Imaris software was used to create
3D images as well as the quantification of pixel intensities.
Supporting Information
Figure S1 Additional Visualization of HA-Srt behavior
by site-specific pulse labeling using sortase A. Cells were
processed as described in Fig. 6A. Merged images of the Qdot 655
(red) and Alexafluor 488 (green) signal are shown. Processed areas
are outlined in white. Scale bars = 5 mm.
(TIF)
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